A T-cell test developed by Adaptive Biotechnologies could become the first commercially available test of its kind, and it may be more effective at detecting past COVID-19 infections than antibody ...
A cluster of recent studies has sharpened the scientific picture of how T cells switch on, tracking the molecular signals ...
The authors compared the CD4+ T-cell counts and HIV-1 RNA viral loads of 383 patients who were either mono-infected with HIV or co-infected with HTLV-1/HIV. They confirmed that co-infected patients ...
In MS trials, investigators are steering those cells toward B‑cell populations that appear to be driving inflammation.
The researchers say that, to their knowledge, this is the first demonstration of programmable, site-specific integration of a ...